MANE R&D Expenses

Veradermics, Incorporated Common Stock · R&D Expenses

MANE logo

MANE R&D Expenses

Latest reported$75.82M
MANE TTM R&D Expenses ($48.82M → $75.82M)
High-resolution chart · PNG

MANE r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Veradermics, Incorporated Common Stock R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
75,821,000
71,543,000
62,065,000
48,823,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.